Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.07
Performance (%)
-7.10%
Price
10.04.26
€71.50
Summary
This prediction is currently active. With a performance of -7.10%, the BUY prediction for Rhythm Pharmaceuticals by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 17.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | -2.667% |
| iShares Core DAX® | 2,55 % |
| iShares Nasdaq 100 | 2,74 % |
| iShares Nikkei 225® | 6,58 % |
| iShares S&P 500 | 1,93 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€84.50
18.02.26
18.02.26
-
18.02.27
18.02.27
-13.61%
10.04.26
10.04.26
